Skip to main content
YARW logo

YARW · Yarrow Bioscience, Inc. · Off Exchange

Track YARW — free
$27.01 -1.43 (-5.03%) At close · Sep 11
Market Cap
$72.11M
Shares
2.67M

Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.

Off-Exchange Volume History

Week Start ATS Volume Non-ATS OTC Volume Total Off-Exchange % of FINRA Weekly Volume
2026-08-03 28,295 35,405 63,700 51.3%
2026-05-04 2,990 35,408 38,398 100.0%
2026-04-27 428 3,033 3,461 100.0%
2026-04-20 524 5,377 5,901 100.0%
2026-04-13 1,518 2,919 4,437 100.0%
2026-04-06 1,099 3,248 4,347 100.0%
2026-03-30 2,740 3,723 6,463 100.0%
2026-03-23 5,257 4,962 10,219 100.0%
2026-03-16 3,607 11,772 15,379 100.0%
2026-03-09 1,073 6,994 8,067 100.0%
2026-03-02 1,755 10,882 12,637 100.0%
2026-02-23 6,000 9,720 15,720 100.0%
2026-02-16 10,818 23,957 34,775 100.0%
2026-02-09 2,669 11,277 13,946 100.0%
2026-02-02 6,108 20,925 27,033 100.0%
2026-01-26 8,339 22,220 30,559 100.0%
2026-01-19 4,603 14,232 18,835 100.0%
2026-01-12 1,171 15,953 17,124 100.0%
2026-01-05 2,621 24,303 26,924 100.0%
2025-12-29 5,892 48,637 54,529 100.0%
2025-12-22 9,068 89,588 98,656 100.0%
2025-12-15 127,410 3,420,241 3,547,651 100.0%
2025-12-08 3,014 64,907 67,921 100.0%
2025-12-01 1,613 34,756 36,369 100.0%
2025-11-24 2,807 35,696 38,503 100.0%
2025-11-17 4,795 80,569 85,364 100.0%
2025-11-10 11,129 71,221 82,350 100.0%
2025-11-03 5,825 105,035 110,860 100.0%
2025-10-27 18,930 140,743 159,673 100.0%
2025-10-20 9,413 88,864 98,277 100.0%
2025-10-13 9,880 127,650 137,530 100.0%
2025-10-06 16,822 344,623 361,445 100.0%
2025-09-29 19,633 250,848 270,481 100.0%
2025-09-22 9,074 112,304 121,378 100.0%
2025-09-15 15,148 125,184 140,332 100.0%
Showing 1–35 of 35 weeks
Key facts CIK 1566044 CUSIP 92941V407 13F (30d) 3 filings 3 filers Visit website Investor relations